
Neurocrine Biosciences (NBIX) Market Capitalization Overview
Market Cap: $14.03B as of Jan 7, 2026
$14.03B
$1.49B (9.57%)past month
As of Jan 7, 2026, Neurocrine Biosciences (NBIX) has a market capitalization of $14.03B. Over the past 30 days, its market cap has decreased by -6.81%, while in the last 12 months, it has decreased by -0.85%.
Market capitalization represents the total value of Neurocrine Biosciences as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Neurocrine Biosciences (NBIX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Neurocrine Biosciences (NBIX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Neurocrine Biosciences as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Neurocrine Biosciences (NBIX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Neurocrine Biosciences (NBIX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Neurocrine Biosciences (NBIX) Market Cap & Key Trends
See Neurocrine Biosciences’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Neurocrine Biosciences (NBIX)
Order type
Buy in
Order amount
Est. shares
0 shares
Neurocrine Biosciences (NBIX) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $15.05B | +6.28% |
| Nov 3, 2025 | $14.16B | +4.17% |
| Oct 1, 2025 | $13.59B | -3.47% |
| Sep 2, 2025 | $14.08B | +10.33% |
| Aug 1, 2025 | $12.76B | +0.71% |
| Jul 1, 2025 | $12.67B | +2.76% |
| Jun 2, 2025 | $12.33B | +16.89% |
| May 1, 2025 | $10.55B | -1.15% |
| Apr 1, 2025 | $10.67B | -6.53% |
| Mar 3, 2025 | $11.42B | -24.89% |
| Feb 3, 2025 | $15.20B | +8.88% |
| Jan 2, 2025 | $13.96B | +9.51% |
Neurocrine Biosciences (NBIX) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $14.03B | -0.85% |
| 2025 | $14.15B | +2.32% |
| 2024 | $13.83B | +6.76% |
| 2023 | $12.95B | +12.74% |
| 2022 | $11.49B | +42.11% |
| 2021 | $8.08B | — |
FAQs About Neurocrine Biosciences (NBIX) Market Cap
As of Jan 7, 2026, the market capitalization of Neurocrine Biosciences (NBIX) is $14.03B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Neurocrine Biosciences’s market capitalization has decreased by -9.57%, changing from $15.51B to $14.03B as of Jan 7, 2026.
In the last 3 months, Neurocrine Biosciences’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Neurocrine Biosciences’s market capitalization increased from $13.83B in January to $14.15B in December, reflecting a 2.32% change.
In the past five years, Neurocrine Biosciences (NBIX) has had a compound annual growth rate (CAGR) of 11.85% in market capitalization. This means its market cap has grown at an average rate of 11.85% per year.